儿童静脉注射肝细胞特异性对比剂进行肝脏增强磁共振成像:放射科医生需要了解的内容
本文概述了肝细胞特异性对比剂(HSCA)在儿童中的临床应用,回顾了可用药物、儿童用药剂量与年龄规格,讨论了HSCA在儿童肝脏和胆道适应症中的影像特征与陷阱,并关注钆沉积问题讨论了儿童使用HSCA的安全性。
要点
- HSCA可被肝细胞摄取并部分排入胆道,较常规细胞外钆对比剂更能改善肝脏病变和胆道异常的定性。
- 本文提供儿童HSCA临床使用指南,涵盖药物选择、剂量及年龄规格。
- 使用HSCA成像时需注意其特有的影像特征及可能遇到的陷阱。
核心结论
- HSCA通过肝细胞摄取和胆道排泄机制,较常规细胞外钆对比剂能改善儿童肝脏病变和胆道异常的定性,本文为放射科医生提供了儿童临床使用指南。
研究设计与样本
- 本文为综述,旨在为放射科医生提供儿童HSCA临床使用指导。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Hepatocyte-specific contrast agents (HSCAs) are a group of intravenous gadolinium-based MRI contrast agents that can be used to characterize hepatobiliary pathology. The mechanism by which these agents are taken up by hepatocytes and partially excreted into the biliary tree improves characterization of hepatic lesions and biliary abnormalities relative to conventional extracellular gadolinium-based contrast agents (GBCAs). This manuscript presents an overview of HSCA use in pediatric patients with the intent to provide radiologists a guide for clinical use. We review available HSCAs and discuss dosing and age specifications for use in children. We also review various hepatic and biliary indications for HSCA use in children, with emphasis on the imaging characteristics distinct to HSCAs, as well as discussion of pitfalls one can encounter when imaging with HSCAs. Given the growing concern regarding gadolinium deposition in soft tissues and brain, we also discuss safety of HSCA use in children.
引用
- Ayyala RS, Anupindi SA, Gee MS, et al. Intravenous gadolinium-based hepatocyte-specific contrast agents (HSCAs) for contrast-enhanced liver magnetic resonance imaging in pediatric patients: what the radiologist should know. Pediatr Radiol. 2019. PMID: 31350632. doi:10.1007/s00247-019-04476-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。